JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5226
Calumet Specialty Products
CLMT
$4.86B
| $21K | ﹤0.01% |
4,904
-2,000
| -29% | -$8K |
2013 Q2
24 quarters
|
|
5227
Comstock Resources
CRK
$3.75B
| $21K | ﹤0.01% |
4,137
-32,600
| -89% | -$189K |
2019 Q1
1 quarter
|
|
5228
iShares Morningstar Small-Cap Growth ETF
ISCG
$971M
| $21K | ﹤0.01% |
612
+366
| +149% | +$12.2K |
2019 Q1
1 quarter
|
|
5229
ProShares Ultra MidCap400
MVV
$144M
| $21K | ﹤0.01% |
518
+300
| +138% | +$11.9K |
2019 Q1
1 quarter
|
|
5230
Nuveen Minnesota Quality Municipal Income Fund
NMS
$64M
| $21K | ﹤0.01% |
1,500
| – | – |
2015 Q3
15 quarters
|
|
5231
ProShares Short QQQ
PSQ
$580M
| $21K | ﹤0.01% |
150
+20
| +15% | +$2.88K |
2019 Q1
1 quarter
|
|
5232
Serina Therapeutics
SER
$49.8M
| $21K | ﹤0.01% |
166
-16
| -9% | -$2.17K |
2018 Q4
2 quarters
|
|
|
IVAC
5233
DELISTED
Intevac Inc
IVAC
| $21K | ﹤0.01% |
4,377
-4,901
| -53% | -$25.7K |
2017 Q4
6 quarters
|
|
|
MBII
5234
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $21K | ﹤0.01% |
14,251
+942
| +7% | +$1.46K |
2018 Q2
4 quarters
|
|
|
GCAP
5235
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $21K | ﹤0.01% |
5,238
-299,736
| -98% | -$1.44M |
2017 Q4
6 quarters
|
|
|
CLSD
5236
DELISTED
Clearside Biomedical
CLSD
| $20K | ﹤0.01% |
1,354
-455
| -25% | -$8.11K |
2017 Q4
6 quarters
|
|
|
CUK
5237
DELISTED
Carnival PLC
CUK
| $20K | ﹤0.01% |
471
-131,147
| -100% | -$6.73M |
2015 Q1
17 quarters
|
|
5238
WisdomTree Japan SmallCap Dividend Fund
DFJ
$453M
| $20K | ﹤0.01% |
300
| – | – |
2018 Q1
5 quarters
|
|
5239
First United
FUNC
$282M
| $20K | ﹤0.01% |
1,040
-628
| -38% | -$11.6K |
2018 Q2
4 quarters
|
|
5240
Inspired Entertainment
INSE
$91.2M
| $20K | ﹤0.01% |
+2,430
| New | +$18.7K |
2019 Q2
0 quarters
|
|
5241
PhenixFIN
PFX
$86.7M
| $20K | ﹤0.01% |
450
| – | – |
2016 Q2
12 quarters
|
|
5242
Sonida Senior Living
SNDA
$1.81B
| $20K | ﹤0.01% |
289
-284
| -50% | -$17.9K |
2015 Q4
14 quarters
|
|
|
SWZ
5243
Swiss Helvetia Fund
SWZ
$74.8M
| $20K | ﹤0.01% |
2,581
| – | – |
2015 Q4
14 quarters
|
|
5244
ProShares Short 20+ Year Treasury ETF
TBF
$140M
| $20K | ﹤0.01% |
1,000
+870
| +669% | +$18.6K |
2019 Q1
1 quarter
|
|
5245
Invesco Trust Investment Grade Municipals
VGM
$483M
| $20K | ﹤0.01% |
1,600
-874,140
| -100% | -$10.8M |
2015 Q4
14 quarters
|
|
5246
Westlake Chemical Partners
WLKP
$750M
| $20K | ﹤0.01% |
825
-525
| -39% | -$12.1K |
2016 Q2
12 quarters
|
|
|
HARP
5247
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $20K | ﹤0.01% |
163
+101
| +163% | +$11.7K |
2019 Q1
1 quarter
|
|
|
RIBT
5248
DELISTED
RiceBran Technologies
RIBT
| $20K | ﹤0.01% |
709
-8,222
| -92% | -$246K |
2018 Q2
4 quarters
|
|
5249
State Street SPDR S&P Global Natural Resources ETF
GNR
$5.09B
| $19K | ﹤0.01% |
426
+74
| +21% | +$3.35K |
2013 Q2
24 quarters
|
|
5250
Maui Land & Pineapple Co
MLP
$312M
| $19K | ﹤0.01% |
1,854
+199
| +12% | +$2.19K |
2017 Q4
6 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.